News
Press Release
November 18, 2022
uMotif – first new validated eCOA/ePRO innovation since paper instruments deployed on smartphones
Press Release
October 12, 2022
uMotif experts to discuss the eCOA/ePRO market – what’s working, what’s wrong, and what patients need now
Press Release
July 19, 2022
uMotif expands leadership team to support growth in US and EU markets
Press Release
June 21, 2022
uMotif and ClinOne unify eCOA / ePRO and eConsent
Press Release
May 25, 2022
$25.5m of new investment from Athyrium Capital Management fund
Blog
April 8, 2022
Achieving more meaningful patient engagement in rare disease trials
Press Release
January 10, 2022
AbbVie and uMotif support rheumatoid arthritis patients with BYOD approach
Press Release
November 17, 2021
uMotif collaborates with The University of Manchester on body mapping tool
Press Release
September 30, 2021